Actively Recruiting
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Led by University of Pennsylvania · Updated on 2026-01-23
700
Participants Needed
13
Research Sites
1182 weeks
Total Duration
On this page
Sponsors
U
University of Pennsylvania
Lead Sponsor
G
GlaxoSmithKline
Collaborating Sponsor
AI-Summary
What this Trial Is About
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.
CONDITIONS
Official Title
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a diagnosis of eosinophilic granulomatosis with polyangiitis
- Parent or guardian willing to provide informed consent, if applicable
You will not qualify if you...
- Inability to give informed consent and to sign the consent form
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 13 locations
1
University of California San Diego
San Diego, California, United States, 92122
Completed
2
National Jewish Health
Denver, Colorado, United States, 80206
Completed
3
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02215
Completed
4
Mayo Clinic
Rochester, Minnesota, United States, 55905
Completed
5
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195
Completed
6
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Completed
7
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15260
Completed
8
University of Utah
Salt Lake City, Utah, United States, 84112
Completed
9
St. Joseph's Healthcare
Hamilton, Ontario, Canada
Actively Recruiting
10
Mount Sinai Hospital
Toronto, Ontario, Canada
Completed
11
medius KLINIK KIRCHHEIM
Kirchheim unter Teck, Germany, 73230
Actively Recruiting
12
AOU Meyer IRCCS
Florence, Italy
Actively Recruiting
13
Imperial College Healthcare NHS Trust/ Imperial College London
London, United Kingdom, W12 0NN
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here